My Trefis
Join Trefis today!
Register to create your own "My Trefis" of stocks, news, and people that interest you.
FILTER BY COMPANY
- All Companies
- Edit My Portfolio
-
Add to watch list:You don't have any companies in your watch list yet.
- My Collection
-
- Abercrombie... ANF
- Aeropostale ARO
- AMD AMD
- American Ea... AEO
- AOL AOL
- Apple AAPL
- Barrick Gol... ABX
- BlackBerry BBRY
- Broadcom BRCM
- Cisco CSCO
- Daimler AG DDAIF
- F5 Networks FFIV
- Ford F
- Gap Inc. GPS
- General Mot... GM
- Google GOOG
- Home Depot HD
- Honda HMC
- HP HPQ
- IBM IBM
- Intel INTC
- Microsoft MSFT
- NetApp NTAP
- Nokia NOK
- nVIDIA NVDA
- NYSE Eurone... NYX
- OpenTable OPEN
- Oracle ORCL
- Toyota TM
- VMware VMW
You don't have any items in your collection. Click next to an item to add it to your collection.
BY CONTRIBUTOR
BY CONTENT
Example question: Bloomberg reported that supply constraints are leading to iPhone shortages. Do Trefis analysts see a meaningful impact on AAPL?
Example comment: Competition will squeeze AMZN's operating margins from 4% to 2% meaning a 10% hit to the stock according to Trefis.
Name (Required)
Email (Required, but never displayed)
SUBMITSUBMIT
Insert Chart or Image...
* Companies:
Dogs of the Dow Jones Industrial Average As Of January 2012
Dogs of the Dow Jones Industrial Average As Of January 2012
Dogs of the Dow Jones by Dividend Yield â Stock, Capital, Investment. Here is an updated sheet of the 10 best Dogs of the Dow. Such stocks have the lowest expected price to earnings ratio and highest dividend yield within the Dow Jones Index. The 10 cheapest stocks of the Dow Jones have an average dividend yield of 3.92 percent and a forward price to earnings ratio of 12.18. The average price to book ratio amounts to 2.46 and price to sales ratio is 1.86. Exactly 40 percent of the stocks have a dividend yield of more than 4 percent. Compared to the results from the previous month, nothing has changed. The cheapest stocks in terms of forward price to earnings are Pfizer (PFE) and Merck (MRK).
Here are the top three stocks with lowest forward P/E ratio:
Pfizer (NYSE:PFE) has a market capitalization of $166.96 billion. The company employs 110,600 people, generates revenues of $67,809.00 million and has a net income of $8,298.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $19,306.00 million. Because of these figures, the EBITDA margin is 28.47 percent (operating margin 13.89 percent and the net profit margin finally 12.24 percent).
Financial Analysis:
The total debt representing 22.58 percent of the company's assets and the total debt in relation to the equity amounts to 50.14 percent. Due to the financial situation, a return on equity of 9.30 percent was realized. Twelve trailing months earnings per share reached a value of $1.27. Last fiscal year, the company paid $0.72 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 17.10, Price/Sales 2.46 and Price/Book ratio 1.98. Dividend Yield: 4.06 percent. The beta ratio is 0.72.
Financial Analysis:
The total debt representing 22.58 percent of the company's assets and the total debt in relation to the equity amounts to 50.14 percent. Due to the financial situation, a return on equity of 9.30 percent was realized. Twelve trailing months earnings per share reached a value of $1.27. Last fiscal year, the company paid $0.72 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 17.10, Price/Sales 2.46 and Price/Book ratio 1.98. Dividend Yield: 4.06 percent. The beta ratio is 0.72.
Merck & Co. (NYSE:MRK) has a market capitalization of $117.89 billion. The company employs 90,000 people, generates revenues of $45,987.00 million and has a net income of $982.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $9,250.00 million. Because of these figures, the EBITDA margin is 20.11 percent (operating margin 3.59 percent and the net profit margin finally 2.14 percent).
Financial Analysis:
The total debt representing 16.90 percent of the company's assets and the total debt in relation to the equity amounts to 32.89 percent. Due to the financial situation, a return on equity of 1.51 percent was realized. Twelve trailing months earnings per share reached a value of $1.46. Last fiscal year, the company paid $1.52 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 26.42, Price/Sales 2.57 and Price/Book ratio 2.20. Dividend Yield: 4.33 percent. The beta ratio is 0.67.
Financial Analysis:
The total debt representing 16.90 percent of the company's assets and the total debt in relation to the equity amounts to 32.89 percent. Due to the financial situation, a return on equity of 1.51 percent was realized. Twelve trailing months earnings per share reached a value of $1.46. Last fiscal year, the company paid $1.52 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 26.42, Price/Sales 2.57 and Price/Book ratio 2.20. Dividend Yield: 4.33 percent. The beta ratio is 0.67.
Intel Corporation (NASDAQ:INTC) has a market capitalization of $136.97 billion. The company employs 100,100 people, generates revenues of $53,999.00 million and has a net income of $12,942.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23,541.00 million. Because of these figures, the EBITDA margin is 43.60 percent (operating margin 32.37 percent and the net profit margin finally 23.97 percent).
Financial Analysis:
The total debt representing 10.31 percent of the company's assets and the total debt in relation to the equity amounts to 15.97 percent. Due to the financial situation, a return on equity of 27.15 percent was realized. Twelve trailing months earnings per share reached a value of $2.40. Last fiscal year, the company paid $0.78 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 11.22, Price/Sales 2.54 and Price/Book ratio 2.98. Dividend Yield: 3.12 percent. The beta ratio is 1.10.
[ less... ]
Financial Analysis:
The total debt representing 10.31 percent of the company's assets and the total debt in relation to the equity amounts to 15.97 percent. Due to the financial situation, a return on equity of 27.15 percent was realized. Twelve trailing months earnings per share reached a value of $2.40. Last fiscal year, the company paid $0.78 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 11.22, Price/Sales 2.54 and Price/Book ratio 2.98. Dividend Yield: 3.12 percent. The beta ratio is 1.10.
Dogs of the Dow Jones Industrial Average As Of January 2012
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span style="font-family: Verdana, sans-serif;"><span lang="EN-US">Dogs of the Dow Jones by </span><span lang="EN-US">Dividend Yield â Stock, Capital, Investment</span><span lang="EN-US">. Here is an updated sheet of the 10 best Dogs of the Dow. Such stocks have the lowest expected price to earnings ratio and highest dividend yield within the Dow Jones Index. The 10 cheapest stocks of the Dow Jones have an average dividend yield of 3.92 percent and a forward price to earnings ratio of 12.18. The average price to book ratio amounts to 2.46 and price to sales ratio is 1.86. Exactly 40 percent of the stocks have a dividend yield of more than 4 percent. Compared to the results from the previous month, nothing has changed. The cheapest stocks in terms of forward price to earnings are Pfizer (PFE) and Merck (MRK).</span></span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"> </div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span lang="EN-US"><span style="font-family: Verdana, sans-serif;">Here are the top three stocks with lowest forward P/E ratio:</span></span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span lang="EN-US"><span style="font-family: Verdana, sans-serif;">
</span></span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span style="font-family: Verdana, sans-serif;">Pfizer (NYSE:PFE) has a market capitalization of $166.96 billion. The company employs 110,600 people, generates revenues of $67,809.00 million and has a net income of $8,298.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $19,306.00 million. Because of these figures, the EBITDA margin is 28.47 percent (operating margin 13.89 percent and the net profit margin finally 12.24 percent). </span><span style="font-family: Verdana, sans-serif;">
</span>
<span style="font-family: Verdana, sans-serif;">Financial Analysis:</span>
<span style="font-family: Verdana, sans-serif;">The total debt representing 22.58 percent of the company's assets and the total debt in relation to the equity amounts to 50.14 percent. Due to the financial situation, a return on equity of 9.30 percent was realized. Twelve trailing months earnings per share reached a value of $1.27. Last fiscal year, the company paid $0.72 in form of dividends to shareholders.</span>
<span style="font-family: Verdana, sans-serif;">Market Valuation:</span>
<span style="font-family: Verdana, sans-serif;">Here are the price ratios of the company: The P/E ratio is 17.10, Price/Sales 2.46 and Price/Book ratio 1.98. Dividend Yield: 4.06 percent. The beta ratio is 0.72.</span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span style="font-family: Verdana, sans-serif;">
</span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span style="font-family: Verdana, sans-serif;">Merck & Co. (NYSE:MRK) has a market capitalization of $117.89 billion. The company employs 90,000 people, generates revenues of $45,987.00 million and has a net income of $982.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $9,250.00 million. Because of these figures, the EBITDA margin is 20.11 percent (operating margin 3.59 percent and the net profit margin finally 2.14 percent). </span><span style="font-family: Verdana, sans-serif;">
</span>
<span style="font-family: Verdana, sans-serif;">Financial Analysis:</span>
<span style="font-family: Verdana, sans-serif;">The total debt representing 16.90 percent of the company's assets and the total debt in relation to the equity amounts to 32.89 percent. Due to the financial situation, a return on equity of 1.51 percent was realized. Twelve trailing months earnings per share reached a value of $1.46. Last fiscal year, the company paid $1.52 in form of dividends to shareholders.</span><span style="font-family: Verdana, sans-serif;">
</span>
<span style="font-family: Verdana, sans-serif;">Market Valuation:</span>
<span style="font-family: Verdana, sans-serif;">Here are the price ratios of the company: The P/E ratio is 26.42, Price/Sales 2.57 and Price/Book ratio 2.20. Dividend Yield: 4.33 percent. The beta ratio is 0.67.</span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span style="font-family: Verdana, sans-serif;">
</span></div>
<div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; line-height: 18px; margin: 0cm;"><span style="font-family: Verdana, sans-serif;">Intel Corporation (NASDAQ:INTC) has a market capitalization of $136.97 billion. The company employs 100,100 people, generates revenues of $53,999.00 million and has a net income of $12,942.00 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23,541.00 million. Because of these figures, the EBITDA margin is 43.60 percent (operating margin 32.37 percent and the net profit margin finally 23.97 percent). </span><span style="font-family: Verdana, sans-serif;">
</span>
<span style="font-family: Verdana, sans-serif;">Financial Analysis:</span>
<span style="font-family: Verdana, sans-serif;">The total debt representing 10.31 percent of the company's assets and the total debt in relation to the equity amounts to 15.97 percent. Due to the financial situation, a return on equity of 27.15 percent was realized. Twelve trailing months earnings per share reached a value of $2.40. Last fiscal year, the company paid $0.78 in form of dividends to shareholders.</span><span style="font-family: Verdana, sans-serif;">
</span>
<span style="font-family: Verdana, sans-serif;">Market Valuation:</span>
<span style="font-family: Verdana, sans-serif;">Here are the price ratios of the company: The P/E ratio is 11.22, Price/Sales 2.54 and Price/Book ratio 2.98. Dividend Yield: 3.12 percent. The beta ratio is 1.10.</span></div>